汉王科技“科技普惠”战略落地 柯氏音电子血压计定价步入两百元阶段

Core Insights - Hanwang Technology launched the KSY3610 and KSY8600 electronic blood pressure monitors, emphasizing affordability and advanced features like atrial fibrillation screening [1][2] - The KSY3610 is priced starting at 259 yuan, aiming to make high-end blood pressure monitoring technology accessible to a broader market [1][2] - The company promotes a "technology for all" philosophy, seeking to provide high-quality health monitoring devices at reasonable prices [1][2] Product Features - The KSY3610 combines the measurement precision of traditional mercury sphygmomanometers with the convenience of electronic devices [2] - It is the only electronic blood pressure monitor in its price range that integrates with the Hanwang Health APP, allowing real-time data synchronization and comprehensive health reporting [2] - The device features an AI-driven health management model, enabling users to ask health-related questions and receive professional answers [2] Market Context - The prevalence of hypertension in China is rising, with a reported rate of 25.2% among individuals aged 18 and older, translating to approximately 270 million patients [2] - This growing patient population presents significant market opportunities for blood pressure monitoring devices [2] Business Strategy - Hanwang's strategy of offering high-functionality products at low prices is expected to rapidly increase market share and brand recognition [3] - While individual product profit margins may decrease, the company anticipates substantial commercial returns through economies of scale and enhanced service value [3] - The introduction of affordable, high-precision health monitoring devices is likely to improve awareness, treatment rates, and control rates of chronic diseases like hypertension [3]